Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.
作者信息
Seelig M S
出版信息
Bacteriol Rev. 1966 Jun;30(2):442-59. doi: 10.1128/br.30.2.442-459.1966.
Abstract
摘要
相似文献
1
Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.抗生素增加念珠菌病发病率和严重程度并改变免疫防御的机制。
Bacteriol Rev. 1966 Jun;30(2):442-59. doi: 10.1128/br.30.2.442-459.1966.
2
[Candidiasis and the effects of antibiotics].[念珠菌病与抗生素的作用]
Mikrobiyol Bul. 1981;15(3-4):207-12.
3
Opportunistic yeast infections, with special reference to candidiasis.机会性酵母菌感染，特别提及念珠菌病。
Ann N Y Acad Sci. 1970 Oct 30;174(2):606-22. doi: 10.1111/j.1749-6632.1970.tb45586.x.
4
Gastrointestinal and disseminated candidiasis. An experimental model in the immunosuppressed rat.胃肠道和播散性念珠菌病。免疫抑制大鼠的实验模型。
Arch Pathol Lab Med. 1981 Mar;105(3):138-43.
5
[Molecular pathogenetic mechanisms and immunity in candidiasis].[念珠菌病的分子致病机制与免疫]
Vestn Dermatol Venerol. 1982 Jun(6):22-9.
6
[Candidiasis & antibiotics during treatment of infections in infants].[婴儿感染治疗期间的念珠菌病与抗生素]
Arch Fr Pediatr. 1958;15(5):716-20.
7
The incidence of Candida albicans after antibiotic therapy.抗生素治疗后白色念珠菌的发病率。
Ir J Med Sci. 1957 Jun(378):265-6. doi: 10.1007/BF02954481.
8
Acute disseminated and chronic mucocutaneous candidiasis.急性播散性念珠菌病和慢性黏膜皮肤念珠菌病。
Semin Hematol. 1971 Jul;8(3):227-42.
9
[Fatal pulmonary mycosis caused by antibiotics].[抗生素所致致命性肺真菌病]
Bull Mem Soc Med Hop Paris. 1954;70(17-18):611-9.
10
[Vulvovaginal mycosis and antibiotics].[外阴阴道霉菌病与抗生素]
Brux Med. 1955 Mar 13;35(11):526-33.
引用本文的文献
1
Gut and bladder fermentation syndromes: a narrative review.肠道和膀胱发酵综合征：叙事性综述。
BMC Med. 2024 Jan 22;22(1):26. doi: 10.1186/s12916-023-03241-7.
2
Impact of Erythromycin as a Prokinetic on the Gut Microbiome in Children with Feeding Intolerance-A Pilot Study.红霉素作为促动力剂对喂养不耐受儿童肠道微生物群的影响——一项试点研究
Antibiotics (Basel). 2023 Nov 8;12(11):1606. doi: 10.3390/antibiotics12111606.
3
Acetate modulates the inhibitory effect of against the pathogenic yeasts and .醋酸盐调节[具体物质]对致病性酵母[酵母名称1]和[酵母名称2]的抑制作用。
Microb Cell. 2023 Mar 21;10(4):88-102. doi: 10.15698/mic2023.04.795. eCollection 2023 Apr 3.
4
Studying Fungal-Bacterial Relationships in the Human Gut Using an In Vitro Model (TIM-2).使用体外模型（TIM-2）研究人类肠道中的真菌-细菌关系
J Fungi (Basel). 2023 Jan 28;9(2):174. doi: 10.3390/jof9020174.
5
Incorporating Microbial Species Interaction in Management of Freshwater Toxic Cyanobacteria: A Systems Science Challenge.将微生物物种相互作用纳入淡水有毒蓝藻管理：一项系统科学挑战。
Aquat Ecol. 2022 Nov 26;3(4):570-587. doi: 10.3390/ecologies3040042.
6
Interactions between and the resident microbiota.[具体内容]与常驻微生物群之间的相互作用。
需注意，原文中“Interactions between and the resident microbiota.”里“between”后面缺少具体内容，以上是根据现有内容翻译的大致框架，补充完整后能得到更准确译文 。
Front Microbiol. 2022 Sep 20;13:930495. doi: 10.3389/fmicb.2022.930495. eCollection 2022.
7
Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow).来自巴西国家药物警戒数据库（Vigimed/VigiFlow）的抗菌药物潜在安全信号。
Front Pharmacol. 2022 Sep 20;13:948339. doi: 10.3389/fphar.2022.948339. eCollection 2022.
8
Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.肠道微生物群的调控作为克罗恩病的关键靶点
Front Med (Lausanne). 2022 Jun 16;9:887044. doi: 10.3389/fmed.2022.887044. eCollection 2022.
9
Oleic Acid-Based Self Micro-Emulsifying Delivery System for Enhancing Antifungal Activities of Clotrimazole.基于油酸的自微乳化给药系统用于增强克霉唑的抗真菌活性
Pharmaceutics. 2022 Feb 22;14(3):478. doi: 10.3390/pharmaceutics14030478.
10
Bacterial-fungal interactions and their impact on microbial pathogenesis.细菌-真菌相互作用及其对微生物发病机制的影响。
Mol Ecol. 2023 May;32(10):2565-2581. doi: 10.1111/mec.16411. Epub 2022 Mar 14.
本文引用的文献
1
Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea.用青霉素治疗感染星状念珠菌的鸡胚后死亡率增加。
J Infect Dis. 1949 Nov-Dec;85(3):268-74. doi: 10.1093/infdis/85.3.268.
2
Endotoxin in pathogenic q fungi.致病性真菌中的内毒素。
J Immunol. 1952 Jul;69(1):89-99.
3
Virulence enhancing activities of aureomycin on Candida albicans.金霉素对白色念珠菌的毒力增强活性。
Proc Soc Exp Biol Med. 1952 Mar;79(3):481-4. doi: 10.3181/00379727-79-19418.
4
Antibiotics and fungous infections.抗生素与真菌感染
J Invest Dermatol. 1952 Mar;18(3):247-60. doi: 10.1038/jid.1952.28.
5
In vivo and in vitro effect of aureomycin hydrochloride on Syringospora (Monilia, Candida) albicans.盐酸金霉素对白色丁香孢霉（念珠菌、假丝酵母）的体内和体外作用
J Lab Clin Med. 1951 May;37(5):703-12.
6
Inhibition of phagocytosis by aureomycin.金霉素对吞噬作用的抑制
Proc Soc Exp Biol Med. 1950 Nov;75(2):367-70. doi: 10.3181/00379727-75-18201.
7
Studies of the resistance to infection in diabetes mellitus: local exudative cellular response.糖尿病感染抵抗力的研究：局部渗出性细胞反应。
J Lab Clin Med. 1962 Jun;59:1008-15.
8
The biology of experimental human cutaneous moniliasis (Candida albicans).实验性人类皮肤念珠菌病（白色念珠菌）的生物学
Arch Dermatol. 1962 Feb;85:233-57. doi: 10.1001/archderm.1962.01590020073009.
9
Current knowledge of type-specific M antigens of group A streptococci.A组链球菌特定类型M抗原的现有知识。
J Immunol. 1962 Sep;89:307-13.
10
Enteric candidiasis. Diagnosis and clinical considerations.肠道念珠菌病。诊断与临床考量
Pediatrics. 1962 Jul;30:71-85.
Zotero 插件